Insider trades
Matthew L. Posard, Director of Nautilus Biotechnology NAUT, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/18.
Matthew L. Posard
Director
- Company
- Nautilus Biotechnology NAUT
- First filing
- 23/05/09
- Trades
- 19 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
HALO | Open-market sale | 24/08/12–24/08/14 | 24/08/14 | 29,881 sh3 trades | $56.53avg. | $1,689,233.7 | −30.0% |
HALO | Open-market sale | 24/06/11–24/06/12 | 24/06/13 | 20,000 sh2 trades | $50.32avg. | $1,006,300 | −16.7% |
